Response to: 'Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a need for a more accurate control group?' by Mertz and Arnaud
- PMID: 32434822
- DOI: 10.1136/annrheumdis-2020-217696
Response to: 'Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a need for a more accurate control group?' by Mertz and Arnaud
Keywords: autoimmune diseases; inflammation; lupus erythematosus, systemic.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.Ann Rheum Dis. 2020 Jun;79(6):793-799. doi: 10.1136/annrheumdis-2020-217013. Epub 2020 Apr 2. Ann Rheum Dis. 2020. PMID: 32241798
-
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a need for a more accurate control group?Ann Rheum Dis. 2022 May;81(5):e83. doi: 10.1136/annrheumdis-2020-217651. Epub 2020 Apr 27. Ann Rheum Dis. 2022. PMID: 32340976 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
